ICLR — ICON PLC
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1060955 ·
Last close
$172.33
Market Cap
$13.30B
52W High
$203.91
52W Low
$66.57
ADV30
805,787
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 2,063,486,000 | 479,294,000 | 194,209,000 | 72,582,000 | 16,400,320,000 | 928,385,000 | 7,022,158,000 |
| Mar 2026 | 2,033,999,000 | 477,926,000 | 186,997,000 | 104,751,000 | 16,319,022,000 | 765,164,000 | 7,018,726,000 |
| Dec 2025 | 2,112,517,000 | 480,738,000 | 210,748,000 | 149,194,000 | 16,269,782,000 | 647,295,000 | 7,076,398,000 |
| Sep 2025 | 2,042,812,000 | 554,448,000 | 258,904,000 | 2,355,000 | 16,507,490,000 | 468,888,000 | 7,172,644,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$536,237,000
Investing CF
$-165,504,000
Financing CF
$235,595,000
CapEx
$-186,222,000
Dividends Paid
—
Buybacks
$250,000,000
EPS Diluted TTM
$0.56
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$2,299,384,000
Inventory
—
Receivables
$2,705,449,000
ST Investments
$0
EBIT TTM
$14,994,000
Pretax Income TTM
$-172,139,000
Interest Exp TTM
$187,133,000
Analysts
16
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,294,416,896
EBITDA
$523,480,992
Free Cash Flow
$622,646,656
Enterprise Value
$15,660,429,312
Total Cash
$928,385,024
Total Debt
$3,525,835,008
Shares Out
77,154,209
Trailing EPS
$0.64
Book Value
$121.55
ROE
0.3%
ROA
1.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,251,340,000 | 1,012,459,000 | 229,339,000 | 16,269,782,000 | 7,076,398,000 | 9,193,384,000 | 1,036,205,000 |
| Dec 2024 | 8,188,990,000 | 1,154,081,000 | 739,126,000 | 16,634,822,000 | 7,193,468,000 | 9,441,354,000 | 1,286,652,000 |
| Dec 2023 | 8,054,926,000 | 994,230,000 | 554,208,000 | 16,864,783,000 | 7,653,337,000 | 9,211,446,000 | 1,161,027,000 |
| Dec 2022 | 7,741,386,000 | 866,075,000 | 505,304,000 | 17,185,278,000 | 8,687,315,000 | 8,497,963,000 | 563,315,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$11.88
Max Pain — expiry 2026-10-16
max pain strike: $165.00 · spot: $172.33 · call oi: 1,833 · put oi: 1,163
Expected Move to 2026-10-16:
±$14.10
(8.18%) —
implied range
$158.23 –
$186.43
· ATM straddle on $170.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $14.11B | $292.84 | — |
| MEDP | Medpace Holdings, Inc. | $17.27B | $618.88 | — |
| INCY | INCYTE CORP | $25.11B | $123.89 | — |
| LNTH | Lantheus Holdings, Inc. | $6.51B | $99.74 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $40.91B | $519.26 | — |
News headlines (Yahoo Finance, 1h cache)
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
2026-08-06 15:29 · Yahoo
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
2026-08-05 14:56 · Yahoo
ICON Public Limited Company (ICLR) Surges on Net Book-to-Bill Strength
2026-07-29 13:16 · Yahoo
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
2026-08-20 12:30 · Yahoo
ICON Announces Pricing of USD 2.15 Billion Notes
2026-08-06 10:30 · Yahoo
ICON Announces Private Offering of Notes
2026-08-04 12:39 · Yahoo
ICON Announces Results of Annual General Meeting
2026-07-31 20:15 · Yahoo
ICON Announces Multi-Year Anthropic Collaboration to Expand AI Across Clinical Trials
2026-07-28 14:04 · Yahoo
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
2026-07-28 11:00 · Yahoo
ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure
2026-09-22 15:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.